# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsui...
Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and develo...
Life sciences company Revive Therapeutics Ltd.
Psychedelics Legislation: The Latest On Hawaii, Virginia, Missouri & More
Considering MDMA will likely be the first psychedelic to receive FDA approval for psychotherapeutic use to treat serious mental...
Ketamine products manufacturer PharmaTher Holdings Ltd. (OTCQB: PHRRF) had lots happening this past week. Here are the company&...
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second ...
Life sciences company Revive Therapeutics Ltd. (OTCQB: RVVTF) raised funds to treat infectious diseases and rare disorders, inc...
Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedel...